Dr. Stephen James Summers, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 30 N 1900 E, Rm 3b420, Salt Lake City, UT 84132 Phone: 801-213-2700 Fax: 801-585-2891 |
Benjamin James Mccormick, Urology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-213-2704 Fax: 801-585-2891 |
Leah Stoehr, APRN Urology - Pediatric Urology Medicare: Medicare Enrolled Practice Location: 100 N Mario Capecchi Dr, Salt Lake City, UT 84113 Phone: 801-662-5555 |
John Evan Thomas, PA-C Urology Medicare: Accepting Medicare Assignments Practice Location: 30 N 1900 E Rm 3b420, Salt Lake City, UT 84132 Phone: 801-213-2700 Fax: 801-585-2891 |
Colton K. Leavitt, MD Urology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 3b427, Salt Lake City, UT 84132 Phone: 801-213-2718 |
Michael W. Mangelson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 389 S 900 E, Salt Lake City, UT 84102 Phone: 385-282-2000 Fax: 385-282-2001 |
Julia Faith Piwowarski, PA-C Urology Medicare: Accepting Medicare Assignments Practice Location: 30 N 1900 E, Salt Lake City, UT 84132 Phone: 801-581-7304 |
Dr. Catherine Rhu Devries, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 100 Mario Capecchi Dr, Salt Lake City, UT 84113 Phone: 801-662-5555 Fax: 801-588-3307 |
Deborah Lynn Jacobson, MD Urology - Pediatric Urology Medicare: Medicare Enrolled Practice Location: 100 N Mario Capecchi Dr Ste 3550, Salt Lake City, UT 84113 Phone: 801-662-5555 Fax: 801-662-5547 |
Sorena Keihani, MD, MSCI Urology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 3b427, Salt Lake City, UT 84132 Phone: 801-213-2700 |
Jeremy Myers, MD Urology Medicare: Accepting Medicare Assignments Practice Location: University Of Utah Division Of Urology, 30 N 1900 E, Rm 3b420, Salt Lake City, UT 84132 Phone: 801-213-2700 Fax: 801-585-2891 |
Dr. Rano Naim Gabra Matta, MD Urology - Pediatric Urology Medicare: Accepting Medicare Assignments Practice Location: 30 N 1900 E Rm 3b427, Salt Lake City, UT 84132 Phone: 801-213-2700 |
Patrick R. Evans, MD Urology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 1a071, Salt Lake City, UT 84132 Phone: 801-581-2868 |
Devon M. Langston, MD Urology Medicare: Medicare Enrolled Practice Location: 30 N Mario Capecchi Dr Rm 4s100, Salt Lake City, UT 84112 Phone: 801-581-2121 |
Dr. Zachary D. Pfeifer, MD Urology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 3b427, Salt Lake City, UT 84132 Phone: 801-213-2718 |
Dr. William O. Brant, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-587-4888 |
Patrick C. Cartwright, MD Urology Medicare: Medicare Enrolled Practice Location: 100 N Medical Dr, 2200, Salt Lake City, UT 84113 Phone: 801-588-3300 |
Mitchell Rulon Bassett, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 |
Brian Patrick Wiseman, MD Urology - Pediatric Urology Medicare: Medicare Enrolled Practice Location: 30 N Mario Capecchi Dr Rm 4s100, Salt Lake City, UT 84112 Phone: 801-581-2121 |
Erin E. Carter, MD Urology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 928-607-4245 |
News Archive
Diamyd MedicalĀ“s US Phase II clinical trial, evaluating the ability of the candidate drug NP2 Enkephalin to reduce cancer pain, is posted on the ClinicalTrials.gov website.
A chemical compound found normally in the blood has shown promise in treating and preventing an intractable form of heart failure in a mouse model of the disease, report researchers at the University of Illinois at Chicago College of Medicine.
The marshmallow test is a simple social-science tests that was developed by Stanford psychologist Walter Mischel around six decades back. In this test a marshmallow is put before a child and they are told that they can have a second one if they can manage to wait 15 minutes before having the first one.
Early results from a UCLA-led clinical trial found treating women with estrogen receptor (ER)-positive and human epidermal growth factor receptor-2 (HER2)-negative early breast cancers with a novel type of anti-hormonal therapy, called an oral selective estrogen receptor degrader (SERD), led to clinically meaningful reductions in tumor activity prior to surgery.
› Verified 5 days ago